Background: Because of the risk for Zika virus infection in the Americas and the links between infection and microcephaly, other serious neurologic conditions, and fetal death, health ministries across the region have advised women to delay pregnancy. However, the effectiveness of this policy in reducing prenatal Zika virus infection has yet to be quantified.
. Zika virus has been isolated from various species of Aedes mosquitoes, including Aedes aegypti, which is the primary vector for the ongoing Zika virus outbreak across Latin America and the Caribbean (2) . The potential for Zika virus transmission by A albopictus raises concern about the threat of dissemination of the virus beyond the habitat range of A aegypti (3) .
Most Zika virus infections are asymptomatic (4) . Symptomatic cases are predominantly mild, characterized by fever, headache, myalgia, maculopapular rash, joint pain, and conjunctivitis (4) . Although Zika virus illnesses are generally self-limiting, the virus can cause serious birth defects, including microcephaly, and neurologic disease, such as Guillain-Barré syndrome (5) (6) (7) . In addition to microcephaly, studies have shown fetal abnormalities among about 30% of infants born to women with confirmed Zika virus infection during pregnancy (8) . These abnormalities can include in utero growth restriction, central nervous system malformations, complications of amniotic fluid volume and artery flow, and fetal death (8 -10).
Studies have estimated more than a doubling of microcephaly cases in Brazil overall from the end of November 2015 to the beginning of February 2016, which has been linked to prenatal Zika virus infection (11) . A surge in central nervous system malformations, including microcephaly, was also recorded during the 2013 Zika virus outbreak in French Polynesia (12) . An elevated number of microcephaly cases has recently been observed in Colombia, to which Zika virus spread in September 2015 (13) .
Health ministries across Latin America and the Caribbean have advised women to postpone pregnancy, with recommended delays of 6 to 8 months in Colombia, 1 year in Jamaica, and 2 years in El Salvador (14) . Health authorities in Brazil and Ecuador have made similar recommendations without specifying the duration (14) . However, these recommendations have not been met by concerted action from governments to facilitate adherence. Without wider availability of effective contraception options throughout Latin America and the Caribbean, people may resort to riskier birth control methods. Furthermore, 56% of all pregnancies in Latin America are unplanned (15, 16) , which may limit the extent to which policy recommendations can affect the timing of pregnancies throughout populations. In addition, a surge in pregnancies is likely to occur after the period of abstention. Consequently, the need is urgent to evaluate the implications of the extent and timing of pregnancy delay as an effective strategy to avert microcephaly and other fetal abnormalities caused by Zika virus infection.
In this study, we developed a data-driven Zika virus transmission model to evaluate the effectiveness of pregnancy-delay recommendations in reducing the incidence and prevalence of prenatal Zika virus infection in Colombia. We hypothesized that the effectiveness of mass pregnancy delays in reducing prenatal Zika virus infections depends on the duration of the delay, the population-level adherence to the policy recommendation, and the timing of initiation of the strategy relative to the peak incidence of infection within the community of interest.
METHODS
In the absence of vaccines or treatments for Zika virus infection, and given the limited evidence on the effectiveness of vector control in curtailing the spread of A aegypti-borne diseases, such as dengue and chikungunya (17) , public health authorities in many countries in the Americas affected by Zika virus have made recommendations to women and couples to postpone pregnancy (14) . When durations have been specified, recommended delays have ranged from 6 months to 2 years. We developed a data-driven Zika virus transmission model to evaluate the effect of a mass pregnancydelay strategy in which women of reproductive age avoid pregnancy for the recommended duration, at varying degrees of adherence.
Mathematical Model
We developed a disease transmission model for the spread of Zika virus in Colombia that included both human and mosquito population dynamics. We stratified the modeled human population by sex (male or female), age (prereproductive, reproductive, or postreproductive), and pregnancy status (nonpregnant or pregnant). We also distinguished between early and later stages of pregnancy to evaluate the conservative assumption in our base case that only women infected during their first trimester are at risk for giving birth to a child with Zika-induced microcephaly (18) . In scenario analyses, we also considered the possibility that Zika virus may cause microcephaly at any point during pregnancy. The model parameters were quantified with entomologic data specific to A aegypti, demographic data specific to Colombia, and epidemiologic data specific to Zika virus and dengue (Table) .
To simulate Zika virus transmission, the mosquito population was subdivided into 3 epidemiologic classes: susceptible (S V ), exposed (E V ), and infected (I V ). Susceptible mosquitoes became exposed (entering the class O E ) at a rate that depended on the human force of infection ( H ), and exposed mosquitoes became infected at a rate that depended on the extrinsic incubation period ( V ). Mosquito population dynamics incorporated seasonality through the mosquito birth rate (39) . We defined the force of infection as a function of The human population was subdivided into 5 epidemiologic classes: susceptible (S H ), exposed (E H ), symptomatic infected (I HS ), asymptomatic infected (I HA ), and recovered (R H ). Susceptible persons became exposed at a rate of O , which depended on the biting rate of mosquitoes, the proportion of infected mosquitoes and their infectivity (␤ V IV/N V , where N V was the total number of adult mosquitoes), and the density ratio of mosquitoes to people (N V /N H ). Thus, O = c ␤ V IV/ N H . Exposed persons became infected at a rate of ␣, with a proportion (r) transitioning into the symptomatic class (I HS ) and a proportion (1 Ϫ r) transitioning into the asymptomatic class (I HA ). Infectious persons recovered at a rate of ␥ into the R H class. We assumed lifelong immunity after infection, consistent with closely related flaviviruses, such as those for dengue (40) and yellow fever (41) , and consistent with the persistence of neutralizing Zika virus antibodies observed in previously infected persons (37) . Further description of the model equations can be found in the Supplement (available at www.annals.org).
Model Fitting
We used a Bayesian melding approach (42) to fit our model to epidemiologic data on weekly suspected and confirmed symptomatic cases of Zika virus infection in Colombia from 11 October 2015 to 31 March 2016 (43) while also accounting for the large proportion of unreported asymptomatic cases typical of Zika virus infection (4). The Bayesian melding approach combined prior information about model input parameters (Table) with data on incidence of Zika virus infection. We implemented a sample-importance-resample algorithm to identify the input parameter values that generated epidemic curves that most closely matched the data on Zika virus infection. Specifically, we ran 200 000 model simulations, sampling randomly from the prior distributions of input parameters in each simulation. Throughout the sampling process, we weighted each simulation according to its likelihoodbased compatibility with the data. We then resampled (with replacement) from the simulations, with the probability of selection proportional to the weight of the simulation. Under this approach, the simulation resampled most frequently (the mode) is considered the best-fitting simulation. The 2.5th and 97.5th percentiles were used to obtain 95% credible intervals (CrIs) for model parameters and output. The 95% CrI is the interval within which the values of the input and output parameters of the model lie with a 95% probability, given the epidemiologic data. After fitting, we validated our model projections against weekly case data from 1 April to 8 May 2016. Further details of the model fitting process can be found in the Supplement.
To compute the value of the basic reproductive number (R 0 ), which is the average number of secondary human infections generated throughout the entire infectious period of a single human (44, 45), we applied the next-generation matrix method (a computational method used to derive R 0 from transmission dynamics models) to our fitted model (44, 45).
Data Sources
Cases reported by the National Institute of Health of Colombia from 11 October 2015 to 8 May 2016 were used to fit our Zika virus transmission model (43) . These reported cases constitute weekly nationwide suspected and laboratory-confirmed cases of Zika virus infection.
Suspected cases were defined as persons presenting at a hospital or clinic with rash, fever (temperature >37.2°C), and at least 1 of the following symptoms within 5 days of symptom onset that could not be explained by other medical conditions: nonpurulent conjunctivitis or conjunctival hyperemia, arthralgia, myalgia, headache, or malaise. In addition, they had to have been in a place at less than 2200 m elevation with autochthonous Zika virus transmission within the 15 days before symptom onset. Laboratory-confirmed cases were suspected cases who had positive results for Zika virus on reverse transcriptase polymerase chain reaction testing.
Statistical Analysis
In addition to mass pregnancy delays, we considered an individual-based, pregnancy-delay strategy, in which women of reproductive age independently de- 
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ORIGINAL RESEARCH cide to postpone pregnancy. In this scenario, the decision to delay pregnancy was made continuously over time rather than at a specific point of time with all other women who decided to delay pregnancy, as with the mass strategy. We evaluated the effect of pregnancy delay on reducing prenatal exposure to Zika virus, as well as the marginal effects of individual decisions to delay pregnancy longer than recommended by health policy.
We conducted a 1-way sensitivity analysis to evaluate the effect of model parameters on the timing of peak incidence of Zika virus infection and the number of cumulative microcephaly cases (to evaluate the effectiveness of mass pregnancy-delay strategies). To assess interactions between pregnancy delay and vectorcontrol measures, we considered varying reductions in rates of mosquito death and biting.
We considered an alternative model structure with the assumption that asymptomatic persons did not contribute to disease transmission. We evaluated the effect of this assumption on R 0 and our projections of prenatal Zika virus infections and microcephaly cases with and without pregnancy delay.
To identify the contribution of each model parameter to the variability of the outcome measure, we calculated the partial rank correlation coefficients (PRCCs) between input and output variables (46) . A positive PRCC is when an increase in an input variable results in an increase in the output variable; a negative PRCC is when an increase in an input variable results in a decrease in the output variable. In addition, the magnitude of the PRCC is a measure of the contribution of an input variable to the uncertainty of an output variable. All analyses were performed using MATLAB R2015b (MathWorks). The code is available at https: //github.com/mln27/ZikaCodes.
Role of the Funding Source
The study was funded by the National Institutes of Health, which had no role in the study design; collection, analysis, or interpretation of the data; writing of the report; or the decision to submit the manuscript for publication.
RESULTS

Model Calibration
Using prior distributions of parameters based on epidemiologic and clinical studies, we derived a posterior distribution for each epidemiologic parameter (Table) for which the model yielded the best estimate of the trajectory of reported cases of Zika virus infection ( Figure 1 ). We validated the weekly incidence of symptomatic cases projected by our model against weekly reported cases in Colombia from 1 April to 8 May 2016. The proportion of cumulative cases of Zika virus infection that occurred among women was estimated by our model to be 65.0% (95% CrI, 62% to 69%) compared with the empirical estimate of 63.6% (47) , and the proportion of cumulative cases that occurred among adults of reproductive age was estimated to be 64.7% (CrI, 59% to 67%) versus the empirical estimate of 62.8% (47) . Our model projections show that Zika virus infection may become endemic in Colombia by mid-2017 ( Figure 1) .
Model Projections and Intervention Effectiveness
We calculated the basic reproductive ratio (R 0 ) of the ongoing Zika virus epidemic in Colombia to be 1.25 (CrI, 0.6 to 2.05). We used the fitted model to estimate the number of cases of Zika virus infection and prenatal infections, both symptomatic and asymptomatic, that would occur by the end of 2016 if the epidemic were to continue unabated. We projected that the outbreak will result in a total of 1.18 (CrI, 0.50 to 2.07) million cases and 11 768 (CrI, 6907 to 22 300) prenatal infections during the first trimester of pregnancy among currently affected communities. Applying the risk for microcephaly associated with Zika virus infection during the first trimester from the French Polynesia outbreak (48), we estimated that 112 (CrI, 50 to 446) microcephaly cases will occur in Colombia from prenatal infection in 2016 from both symptomatic and asymptomatic cases. Alternatively, if the risk for microcephaly is associated with infection at any time during pregnancy, the estimate of prenatal infections increases to 29 230 (CrI, 17 760 to 56 500) in 2016, leading to 278 (CrI, 126 to 860) microcephaly cases. These estimates are probably conservative given that the rate of microcephaly seems to have been much lower in the French Polynesia outbreak than in the ongoing outbreak in the Americas (8, 48, 49) .
We evaluated the effect of mass pregnancy-delay strategies ranging from 3 to 24 months for mitigating 
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prenatal Zika virus infection from the onset of the outbreak until June 2017. We found that if the delay was initiated 1 week after the onset of the epidemic, delays of 6 months or less were likely to increase prenatal exposure and the prevalence of microcephaly cases compared with no delay (Figure 2) . Moreover, the effectiveness of these short-duration strategies was shown to decrease with increasing adherence (Figure 3, top) . This paradoxical exacerbation arises because the surge in pregnancies after the period of abstinence would occur near the incidence peak of the epidemic (Figure 2) . We compared the effectiveness of mass strategies versus individual-based strategies, where women independently choose to postpone pregnancy. For delays of 9 months or longer, mass strategies were more effective than individual-based strategies at reducing prenatal infections (Figure 3) . Mass strategies were less effective than individual-based strategies for delays of 6 months or less ( Figure 3) . With 50% adherence to 3-to 6-month pregnancy-delay recommendations, the incidence of prenatal exposure was projected to increase by 2.1% (CrI, Ϫ4.6% to 2.1%) to 7.6% (CrI, Ϫ5.6% to 8.7%) for mass strategies and, conversely, to decrease by 7.5% (CrI, 3.0% to 8.2%) to 8.9% (CrI, 3.2% to 10.1%) for individual-based strategies (Figure 3, middle) . For delays of 9 to 24 months, mass strategies decreased prenatal incidence by 16.8% (CrI, 1.9% to 35.5%) to 43.8% (CrI, 40.3% to 47.2%), and individual-based strategies reduced incidence by 9.5% (CrI, 2.3% to 10.9%) to 10.3% (CrI, 3.3% to 12.1%) (Figure 3, middle) . We evaluated the marginal benefit of individual decisions to delay pregnancy beyond the recommended duration for a mass strategy. For a 6-month mass strategy, an extended individual delay was predicted to result in an incremental reduction in prenatal infections of 10.4% (CrI, 6.9% to 16.9%) to 21.4% (CrI, 10.8% to 27.8%), depending on the adherence to and duration of the individual delay (Figure 3, bottom) .
We evaluated the effect of the timing of initiation of a delay in pregnancy on the effectiveness of mass strategies. We found that the optimal timing for initiation of a recommended delay depended on its duration (Figure 4) . A 6-month delay was most effective when it was initiated 4 months into the outbreak, whereas the optimal timing of initiation of a 9-month delay was 2 months into the outbreak (Figure 4) . However, regardless of the stage of the epidemic at which the delay was initiated, a delay of more than 6 months was shown to be more effective in reducing prenatal exposure than a shorter delay (Figure 4 ).
Scenario and Global Sensitivity Analyses
Our 1-way sensitivity analysis indicated that the A aegypti biting rate on humans, the relative risk for exposure to Zika virus in women of reproductive age, and the vector density-dependent mosquito-to-human transmission rate had the greatest effect on the time to peak incidence from the onset of the outbreak and the number of microcephaly cases (Supplement Figure 3) . Specifically, we showed that the time to peak incidence increased and the number of microcephaly cases de- Reduction in cumulative incidence with individual-based strategy. Bottom. Incremental increase in incidence reduction for individual decisions to delay pregnancy beyond a 6-mo mass delay.
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To evaluate the effect of the infectiousness of asymptomatic cases on our model projections, we considered an alternative model structure with the assumption that only symptomatic cases were infectious (Table and Supplement Figure 4) . Under this assumption, we estimated R 0 in Colombia to be 3.27 (CrI, 2.15 to 5.47) and estimated that the outbreak would result in a total of 1.04 (CrI, 0.60 to 2.45) million cases and 11 777 (CrI, 7424 to 23 375) prenatal infections during the first trimester of pregnancy by July 2017. The proportion of cumulative cases of Zika virus infection that occurred among women was estimated to be 68.2% (CrI, 62% to 69%), and the proportion of cumulative cases that occurred among men or women of reproductive age was estimated to be 66.1% (CrI, 59% to 67%). Results of interventions (not shown) were similar to the base-case scenario for which asymptomatic and symptomatic cases were assumed to be equally infectious.
The global sensitivity analysis showed that the period of human infectiousness, A aegypti lifespan, and relatively elevated risk for Zika virus infection in women of reproductive age had an appreciable effect on the number of prenatal infections in the 2 transmission scenarios (Supplement Figure 5) . When we assumed that only symptomatic cases were infectious, the proportion of such cases was shown to have a substantial effect on the number of prenatal infections (Supplement Figure 5 ).
DISCUSSION
We evaluated the effect of delaying pregnancy as an intervention strategy for mitigating prenatal Zika virus infections during an outbreak. Our results show that pregnancy-delay strategies are more effective at reducing prenatal exposure when the delay lasts more than 6 months and is initiated early in an outbreak. Because the incidence peak of the epidemic occurs around 8 months into the outbreak, a strategy to delay pregnancy by more than 9 months, initiated at the onset of the epidemic, would allow women of reproductive age to avoid being pregnant during the incidence peak, when risk for exposure to Zika virus is highest. A strategy to delay pregnancy by 6 months or less, initiated at the onset of the epidemic, is likely to exacerbate prenatal exposures due to the surge in pregnancies after the period of abstinence that may occur near the incidence peak of the epidemic. Consequently, the optimal duration of a delay in pregnancy depends on the stage at which an affected community is in the epidemic, which will determine the timing of the local incidence peak and the period of highest risk for exposure to Zika virus for pregnant women.
Cases of sexual transmission of Zika virus from infected men to female partners have been reported during outbreaks (50, 51) , likely due to the presence of the virus in the semen of infected men (52) . Because most cases of Zika virus infection are asymptomatic, preg- 
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nant women are at risk for contracting the virus from either infected A aegypti mosquitoes or infected partners. Given the limited data on sexual transmission, we did not explicitly account for it in our model. Nonetheless, fitting our model to incidence data did implicitly account for cases that arose from sexual transmission; therefore, this transmission route was effectively subsumed within our overall rate of transmission. We anticipate that explicitly accounting for sexual transmission could result in higher effectiveness in reducing prenatal infections for pregnancy delays longer than 6 months due to the apparent longer-term persistence of Zika virus in semen versus mosquitoes (53). As more data on the risk for sexual transmission of the virus become available, future studies should investigate its relative contribution to outbreaks.
The quantitative results of our study could be refined as more accurate data on laboratory-confirmed and validated suspected cases become available. Although the data we used for our analysis are the only publicly available epidemiologic data on Zika virus infection in Colombia, fewer than 10% of these reported cases are laboratory-confirmed, and symptoms among persons with suspected infection may also be attributable to other causes, such as dengue and chikungunya, which are cocirculating in Colombia (54) . Moreover, many cases of Zika virus infection are probably not reported because of the high rate of mild and asymptomatic cases observed during previous outbreaks (4, 5) . Therefore, more data are urgently needed to assess the magnitude of the ongoing outbreak in the Americas.
However, data refinement is unlikely to affect the qualitative nature of our results with regard to the effectiveness of mass and individual-based pregnancy-delay strategies, which were shown to be robust to a wide range of parameter values through extensive uncertainty and sensitivity analyses.
Our analysis did not focus on the feasibility of a specific birth control method. Rather, we evaluated the impact of any effective pregnancy-delay strategy in reducing prenatal exposure to Zika virus in communities in the Americas that are at risk for an outbreak. Practical birth control measures that could be implemented for individual-based and mass pregnancy-delay strategies include condom use, oral contraceptives, intrauterine devices, contraceptive injections, and abstinence, although widespread implementation of these methods may be challenging due to the sociocultural composition of the affected countries and the high rate of unplanned pregnancies (15, 16) . Sociologic studies are needed to evaluate the acceptability and feasibility of large-scale delays in pregnancy and the likely rate of adherence in different sociocultural settings. Ultimately, advocating for large-scale delays in pregnancy without providing effective birth control measures is of limited utility. Thus, pregnancy-delay guidelines should be provided in conjunction with widespread dissemination of effective contraceptive measures and education.
Overall, mass delays in pregnancy may be an effective strategy for mitigating the burden of prenatal Zika virus infection within affected communities and communities at imminent risk for outbreaks. However, a mass delay should be used as a reactive strategy rather than a preemptive one, particularly if adherence to the recommendation wanes before the epidemic peaks. Consideration of the demographic and socioeconomic repercussions of prolonged pregnancy delays on affected communities should also be considered. In our analysis, reported cases of Zika virus infection in Colombia were the sole source for estimates of the timing of the incidence peak of the epidemic. Additional epidemiologic data are urgently needed to better characterize the timing of peak incidence for a Zika virus outbreak in a given community.
Given the current Zika virus outbreak in Puerto Rico and the risk for dissemination of the virus to the Gulf Coast region of the continental United States, the Centers for Disease Control and Prevention has issued recommendations on the timing of pregnancy after exposure to Zika virus and the harms of unprotected sexual intercourse during pregnancy in areas of autochthonous transmission and with male partners who have or are at risk for infection (55). Our results indicate that in regions with risk for autochthonous transmission, a mass pregnancy delay of 9 months would probably be an effective strategy for mitigating Zika-induced microcephaly cases and would balance the risk for potential exacerbation of prenatal exposure that could arise from clustering of pregnancies around the peak of the epidemic. Individual decisions to delay pregnancy should account for the local incidence of Zika virus infection, which highlights the importance of surveillance, monitoring, and reporting by the Centers for Disease Control and Prevention.
Our results indicate that delays in pregnancy alone will probably be insufficient to curtail Zika-related birth abnormalities. In the absence of a vaccine or therapeutic drugs for Zika virus infection, a combination of mass and individual pregnancy-delay strategies with effective vector-control measures is needed to curtail the spread and burden of the ongoing outbreak in the Americas. Our analyses suggest that delaying pregnancy in response to Zika virus outbreaks has the potential to be an effective component of a multifaceted strategy for reducing the effect of potential Zikainduced severe birth defects.
